The drug is "
Erbitux". The following are parts of an article in my local Gannett paper printed on June 6, 2004; It was approved in February for treatment of Colon cancer and studies released at the Oncology conference in June "showed remarkable benefit against tumors of the tongue, tonsils and voice box". The article references a company sponsored study of patients with Head and neck cancers that had not spread beyond the neck which was conducted by a doctor, James Bonner, from the university of Alabama. A Dr. Mayer of Dana-Farber is quoted as saying, "Nobody anticipated this degree of positive outcome." This should provide sufficient information for an internet search. Let me know if you need more info.
